MISSED OUT ON THE LATEST CLINICAL GUIDELINE ANNOUNCEMENTS?
No problem, we’ve got you covered! Here’s a list to all guidelines and FDA approvals that were published last month.
- Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations
- Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations
- Testing of Transplant Candidates Aged <12 Years for Infection with HIV, Hepatitis B Virus, and Hepatitis C Virus
- Treatment and Prophylaxis of Venous Thromboembolism in Patients with Cancer Including Patients with COVID-19
EXCLUSIVE SOCIETY GUIDELINES AND MANY MORE!
Search, bookmark, add notes and create your personal clinical guideline library with your digital copy or one of our society and specialty subscription bundles.
JULY 8, 2022 KRYSTEXXA & METHOTREXATE
To lower serum uric acid levels (sUA) in patients with chronic gout
JULY 12, 2022 BLUDIGO
For Cystoscopic Assessment of the Ureters Following Urological and Gynecological Surgical Procedures
JULY 14, 2022 XALKROI
For adult and pediatric patients 1 year of age and older with unresectable, recurrent, or refractory inflammatory anaplastic lymphoma kinase (ALK)-positive myofibroblastic tumors (IMT)
JULY 18, 2022 ZONISADE
Treatment of Partial-Onset Seizures
JULY 19, 2022 OPZELURA
Treatment of nonsegmental vitiligo in patients aged 12 years or older
JULY 27, 2022 BENLYSTA
For the treatment of adults and children aged 5 to 17 with active lupus nephritis (LN) who are receiving standard therapy. Lupus nephritis is a serious inflammation of the kidneys caused by lupus, which can lead to end-stage kidney disease, requiring dialysis or a kidney transplant
JULY 29, 2022 ZORYVE
Treatment of plaque psoriasis, including intertriginous areas, in patients 12 years of age or older
Copyright © 2022 Guideline Central, All rights reserved.